Safety and Efficacy Study of RP4010, in Patients With Relapsed or Refractory Lymphomas
Clinical trial NCT03119467 · TERMINATED
Trial details
- NCT number
- NCT03119467
- Sponsor
- Rhizen Pharmaceuticals SA
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-11
- Primary completion
- 2019-11-29
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.